Abstract
Described is a pretargeting method, and related kits, for targeted medical imaging and/or therapeutics, wherein use is made of abiotic reactive chemical groups that exhibit bio-orthogonal reactivity towards each other. The invention involves the use of [4+2] inverse electron demand (retro) Diels-Alder chemistry in providing the coupling between a Pre-targeting Probe and an Effector Probe. To this end one of these probes comprises an electron-deficient tetrazine or other suitable diene, and the other an alkene or alkyne dienohile.
Original language | English |
---|---|
Patent number | US2012039803 |
IPC | C07D 401/ 14 A I |
Priority date | 12/04/10 |
Publication status | Published - 16 Feb 2012 |
Externally published | Yes |